TITLE

Tarsal-tunnel syndrome is rheumatoid arthritis

AUTHOR(S)
Chater, E H
PUB. DATE
August 1970
SOURCE
British Medical Journal;8/15/1970, Vol. 3 Issue 5719, p406
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64097700

 

Related Articles

  • Tarsal Tunnel. Milidantri, Jim // Podiatry Management;Apr/May2006, Vol. 25 Issue 4, p26 

    Presents a letter to the editor about the development of tarsal-tunnel syndrome in a patient treated with shock wave therapy for heel pain.

  • SLE precipitated by antibodies in a patient with Sjogren's syndrome and rheumatoid arthritis.  // British Medical Journal;11/15/1975, Vol. 4 Issue 5993, p385 

    Examines the association of systemic lupus erythematosus (SLE) antibodies on patients with Sjogren's syndrome and rheumatoid arthritis. Development of SLE after antibiotic and co-trimoxazole intake for rheumatoid arthritis; Precipitation of antibiotics on SLE; Distinction of rheumatoid...

  • Rheumatoid arthritis.  // GP: General Practitioner;5/27/2002, p73 

    Presents a clinical review of rheumatoid arthritis. Epidemiology of rheumatoid arthritis; Therapeutics for rheumatoid arthritis; Causal factor of rheumatoid arthritis.

  • Etanercept.  // Reactions Weekly;2/13/2010, Issue 1288, p18 

    The article describes the case of a child who developed macrophage activation syndrome while receiving etanercept for systemic juvenile rheumatoid arthritis.

  • Abnormalities on the multifocal electroretingram may precede clinical signs of hydroxychloroquine retinotoxicity. Teoh, S. C.-B.; Lim, J.; Koh, A.; Lim, T.; Fu, E. // Eye;Jan2006, Vol. 20 Issue 1, p129 

    A letter to the editor about the side effects of hydroxychloroquine in treating systemic lupus erythematosus, rheumatoid arthritis and Sjörgen syndrome is presented.

  • Periodontal disease in rheumatoid arthritis and Sjogren’s syndrome: a modifiable risk factor for atherosclerosis? Rachapalli, Satish // Rheumatology International;Feb2009, Vol. 29 Issue 4, p479 

    A letter to the editor is presented in response to the article on the prevalence of periodontal disease in rheumatoid arthritis and Sjogren's syndrome previously published.

  • Adalimumab.  // Reactions Weekly;6/15/2013, Issue 1457, p5 

    An abstract of the article "Stevens-Johnson syndrome complicating adalimumab therapy in rheumatoid arthritis disease" by A. Mounach and colleagues is presented.

  • Prevalence of Metabolic Syndrome in Patients with Rheumatoid Arthritis. Mesc#x0130;, Banu; OĞuz, Aytekin; Akbal, Ayla // Turkish Journal of Rheumatology;Mar2011, Vol. 26 Issue 1, p86 

    A letter to the editor and a reply is presented in response to the article "Metabolic Syndrome in Patients With Rheumatoid Arthritis," by A. Akbal and colleagues in the 2009 issue.

  • Bucillamine.  // Reactions Weekly;2/5/2011, Issue 1337, p11 

    The article describes a case of yellow nail syndrome that developed in a woman during treatment with bucillamine for rheumatoid arthritis.

  • Leflunomide/methotrexate.  // Reactions Weekly;7/22/2006, Issue 1111, p15 

    The article presents a study conducted on patients who developed myelodysplastic syndrome during treatment with leflunomide or methotrexate for rheumatoid arthritis (RA).

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics